Skip to content

Van Hav'RX

Active Private limited companyfounded 2025active for 1 yearAvenue de l'Observatoire 158, 4000 LiègeKBO/BCE: BE 1021.273.705

Lifetime

1 annual account with figures
peak of €380,079 in 2025
€380,079 
peak of €280,662 in 2025
€280,662 
peak of €5,662 in 2025
€5,662 
€398,081 
Board1 name since 2025
1 director
Documentsfilings and deeds
19-06-202642 days before the deadline
2025micro format
Incorporation 24-03Dividend €280,0001 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Debts

€398,081 99% of the balance sheet
Suppliers 1%Taxes and wages 29%Other 70%

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 320 companies had the same profile as Van Hav'RX has now. Each dot is one company, two years later.

96.6%
were still trading
2.5%
stopped another way
0.9%
went bankrupt
  • Micro
  • under 2 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 320 companies, not a prediction for Van Hav'RX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-03-2025
  • 100 sharesdeed of 24-03-2025
Board & ownership

Recent changes

Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 24-03-2025 · Gazette deed
All 3 events

Official details

Source: KBO
Status
Active since 20-03-2025Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 2 activities
Establishment unit
2.372.132.6244000 Liège, since 20-03-2025
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€403,743
Filing
Filed on 19-06-2026, 42 days before the end of the filing period
Financials

Insights on Van Hav'RX

Van Hav'RX has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,662 and a net result of €280,662.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Van Hav'RX

What is the company number of Van Hav'RX?
The company number of Van Hav'RX is 1021.273.705. The VAT number is the same number with BE in front: BE 1021.273.705.
Where is Van Hav'RX based?
The registered office is at Avenue de l'Observatoire 158, 4000 Liège.Company details
What does Van Hav'RX do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of Van Hav'RX?
Van Hav'RX is a private limited company (BV).
When was Van Hav'RX founded?
Van Hav'RX was founded on 20-03-2025.
Is Van Hav'RX still active?
Yes, Van Hav'RX is an active enterprise in the KBO register.
What is the turnover of Van Hav'RX?
The turnover of Van Hav'RX was €0 in financial year 2025, according to the filed annual accounts.Financials
Is Van Hav'RX profitable?
In financial year 2025, Van Hav'RX made a profit of €280,662.
Where can I find the annual accounts of Van Hav'RX?
Van Hav'RX filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of Van Hav'RX due?
Van Hav'RX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.